US5132405A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biosynthetic antibody binding sites
Assignee: Creative Biomolecules Inc
•
Filing: 1988-06-30
•
Granted: 1992-07-21
•
Expires: 2008-06-30
Abstract
Abstract Disclosed are a family of synthetic proteins having affinity for a preselected antigen. The proteins are characterized by one or more sequences The United States government has rights in this invention pursuant to small business innovation research grant number SSS-4 1 R43 CA39870-01 and SSS-4 2 R44 CA39870-02. This application is a continuation of copending application Ser. No. 052,800 filed May 21, 1987.
Inventors
- 👤 James S. Huston
- 👤 Hermann Oppermann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 13:00
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/46; C07K16/461; C07K16/464; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/62; C07K2317/00; C07K2317/20; C07K2317/24; C07K2317/60; C07K2317/62; C07K2317/622; C07K2317/624; C07K2319/00; C07K2319/01; C07K2319/02; C07K2319/70; C07K2319/705; Y; Y10; Y10S; Y10S424/00; Y10S424/80; Y10S424/801; Y10S530/00; Y10S530/866; Y10S530/867
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
240 words
A single polypeptide chain comprising: two polypeptide domains connected by a polypeptide linker spanning the distance between the C-terminus of one domain to the N-terminus of the other and defining a single and complete site for binding a preselected antigen, wherein the amino acid sequence of one of said polypeptide domains comprises a heavy chain variable region, and the amino acid sequence of the other of said polypeptide domains comprises a light chain variable region, wherein at least one of said polypeptide domains comprises: a recombinant polypeptide comprising: a set of CDR amino acid sequences together defining a recognition site for said preselected antigen, wherein said CDR sequences are homologous to sequences obtained from a first immunoglobulin, a set of FR amino acid sequences linked to said set of CDR sequences, wherein said FR amino acid sequences are homologous to sequences obtained from a second immunoglobulin, said linked sets of CDR and FR amino acid sequences together defining a hybrid chimeric immunoglobulin variable region binding domain which is immonologically reactive with said preselected antigen; and a third amino acid sequence, peptide bonded to the N- or C- terminus of said site for binding, said third amino acid sequence comprising a single polypeptide chain having a conformation which confers biological activity to said third sequence under the same conditions that allow binding of said site for binding to said preselected antigen, said biological activity being independent of said site for binding.
Claim 2
Dependent Claim
240 words
A single polypeptide chain comprising: two polypeptide domains connected by a polypeptide linker spanning the distance between the C-terminus of one domain to the N-terminus of the other and defining a single and complete site for binding a preselected antigen, wherein the amino acid sequence of one of said polypeptide domains comprises a heavy chain variable region, and the amino acid sequence of the other of said polypeptide domains comprises a light chain variable region, wherein at least one of said polypeptide domains comprises: a recombinant polypeptide comprising: a set of CDR amino acid sequences together defining a recognition site for said preselected antigen, wherein said CDR sequences are homologous to sequences obtained from a first immunoglobulin, a set of FR amino acid sequences linked to said set of CDR sequences, wherein said FR amino acid sequences are homologous to sequences obtained from a second immunoglobulin, said linked sets of CDR and FR amino acid sequences together defining a hybrid chimeric immunoglobulin variable region binding domain which is immonologically reactive with said preselected antigen; and a third amino acid sequence, peptide bonded to the N- or C- terminus of said site for binding, said third amino acid sequence comprising a single polypeptide chain having a conformation which confers biological activity to said third sequence under the same conditions that allow binding of said site for binding to said preselected antigen, said biological activity being independent of said site for binding.
Claim 3
Dependent Claim
14 words
The polypeptide chain of claim 1 wherein the FR sequences are of human origin.
Claim 4
Dependent Claim
180 words
A single chain recombinant protein comprising a first polypeptide region peptide bonded to at least one other polypeptide region, one of said regions being immunologically reactive with a preselected antigenic site and comprising two polypeptide domains with the C-terminus of one peptide bonded to the N-terminus of the other through a polypeptide linker, each of said domains comprising a set of CDR amino acid sequences interposed between a set of FR amino acid sequences, said sets of CDR and FR sequences in said domains together defining a binding site immunologically reactive with said preselected antigenic site, wherein the FR sequences are homologous with sequences obtained from a human immunoglobulin and the CDR sequences are non-human CDR sequences, another of said polypeptide regions being peptide bonded to the N- or C-terminus of said immunologically reactive binding site and comprising a single chain polypeptide having a conformation which confers biological activity to said another region under the same conditions that allow binding of said binding site region to said preselected antigenic site, said biological activity being independent of said binding site region.
Claim 5
Dependent Claim
180 words
A single chain recombinant protein comprising a first polypeptide region peptide bonded to at least one other polypeptide region, one of said regions being immunologically reactive with a preselected antigenic site and comprising two polypeptide domains with the C-terminus of one peptide bonded to the N-terminus of the other through a polypeptide linker, each of said domains comprising a set of CDR amino acid sequences interposed between a set of FR amino acid sequences, said sets of CDR and FR sequences in said domains together defining a binding site immunologically reactive with said preselected antigenic site, wherein the FR sequences are homologous with sequences obtained from a human immunoglobulin and the CDR sequences are non-human CDR sequences, another of said polypeptide regions being peptide bonded to the N- or C-terminus of said immunologically reactive binding site and comprising a single chain polypeptide having a conformation which confers biological activity to said another region under the same conditions that allow binding of said binding site region to said preselected antigenic site, said biological activity being independent of said binding site region.
Claim 6
Dependent Claim
14 words
The recombinant protein of claim 3 wherein the CDR sequences are of murine origin.
References Cited (Backward Citations)
US4474893A
Cited
US4642334A
Cited
EP0088994B1
Cited
US4666837A
Cited
EP0120694A2
Cited
GB2137631A
Cited
EP0125023A1
Cited
WO1986000090A1
Cited
EP0171496A2
Cited
EP0173494A2
Cited
WO1986001533A1
Cited
EP0183964A1
Cited
EP0184187A2
Cited
EP0193161A2
Cited
EP0205326A2
Cited
WO1987002671A1
Cited
GB2188638A
Cited
US4704692A
Cited
WO1988001775A1
Cited
WO1988001649A1
Cited
US4946778A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-07-21 | 1996-01-20 | 1996-07-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-07-21 | 2000-01-20 | 2000-07-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-07-21 | 2004-01-20 | 2004-07-21 | $7700.00 | Window Closed / Lapsed |